FAQ

Lactobacillus reuteri 100000000 UNT Chewable Tablet

Known as: Lactobacillus reuteri 100 Million Cells Chewable Tablet, Lactobacillus reuteri 100 Million UNT Chewable Tablet, Lactobacillus reuteri 100,000,000 UNT Chewable Tablet 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2017
02420052017

Related topics

Related topics

2 relations
Chewable Tablet

Narrower (1)

Lactobacillus reuteri 100000000 UNT Chewable Tablet [Pedia-Lax Probiotic]

Related mentions per year

Related mentions per year

1966-2018
1960198020002020
Lactobacillus reuteri 100000000 UNT Chewable Tablet
Chewable Tablet
Lactobacillus reuteri 100000000 UNT Chewable Tablet [Pedia-Lax Probiotic]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Randomized pilot study on probiotic effects on recurrent candidiasis in oral lichen planus patients.
Some patients with oral lichen planus (OLP) experience recurrent oral candidiasis(OC). Probiotic bacteria have shown to reduce… (More)
Is this relevant?
2012
2012
Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial
Background/Objectives:The percentage of hypercholesterolemic individuals not reaching their LDL-cholesterol (LDL-C) goal remains… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2012
2012
Lactobacillus reuteri ATCC 55730 and L22 display probiotic potential in vitro and protect against Salmonella-induced pullorum disease in a chick model of infection.
Lactobacillus reuteri ATCC 55730 (L. reuteri ATCC 55730) and L. reuteri L22 were studied for their probiotic potential. These two… (More)
Is this relevant?
2012
2012
Lactobacillus reuteri Prevents Diet-Induced Obesity, but not Atherosclerosis, in a Strain Dependent Fashion in Apoe−/− Mice
OBJECTIVE To investigate whether the specific strains of Lactobacillus reuteri modulates the metabolic syndrome in Apoe-/- mice… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 4
Is this relevant?
2010
2010
Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: a preliminary randomized clinical trial
OBJECTIVES The aim of this study was to evaluate the effects of Lactobacilli reuteri (Prodentis) alone and in combination with… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2008
2008
The complete coenzyme B12 biosynthesis gene cluster of Lactobacillus reuteri CRL1098.
The coenzyme B(12) production pathway in Lactobacillus reuteri has been deduced using a combination of genetic, biochemical and… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial.
BACKGROUND An altered microbial exposure may underlie the increase of allergic diseases in affluent societies. Probiotics may… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Salivary mutans streptococci and lactobacilli levels after ingestion of the probiotic bacterium Lactobacillus reuteri ATCC 55730 by straws or tablets.
OBJECTIVE Previous studies have suggested that lactobacilli-derived probiotics in dairy products may affect oral ecology, but the… (More)
Is this relevant?
2005
2005
Transformation ofLactobacillus reuteri with electroporation: Studies on the erythromycin resistance plasmid pLUL631
A high-frequency transformation system was developed forLactobacillus reuteri with the electroporation technique. With this… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2005
2005
Increasing work-place healthiness with the probiotic Lactobacillus reuteri: A randomised, double-blind placebo-controlled study
BACKGROUND Short term illnesses, usually caused by respiratory or gastrointestinal diseases are disruptive to productivity and… (More)
  • table 1
  • table 2
Is this relevant?